Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...

Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and lecanemab, were rejected by the Scottish Medicines Consortium (SMC), ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

The approval of a new drug that can slow the progress of Alzheimer’s disease is being hailed as a historic moment in the ...

Health Canada recently authorized use of lecanemab, but experts say the drug is an incremental benefit, not a cure ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

After decades of unsuccessful research, two new drugs and a pioneering blood test have recently given Alzheimer's patients hope of fighting back against the debilitating disease - but questions remain ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...